TYLER BATES: Open Payments
NPI 1508575374 · GRANVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 22 payments from 11 companies in 2025. Trend: 2023 $182 · 2024 $214 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $91 |
| Novo Nordisk Inc | 4 | $73 |
| Abbott Laboratories | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Veozah, FREESTYLE LIBRE 3, FARXIGA, Ozempic, Auvelity, REXULTI, QULIPTA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
